Interchangeable Biologics Clarity Act

12/29/2022, 4:48 PM

Interchangeable Biologics Clarity Act

This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.

Congress
117
Number
S - 4303
Introduced on
2022-05-25
# Amendments
0
Sponsors
+5
Cosponsors
+5

Variations and Revisions

5/25/2022
Text
PDF
XML

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Interchangeable Biologics Clarity Act

This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.

Alternative Names
Official Title as IntroducedA bill to provide for a period of exclusivity for first interchangeable biological products.
Policy Areas
Health

Comments

Related

Bill Update Alert:  FDASLA Act of 2022

Recent Activity

Latest Summary10/18/2022

Interchangeable Biologics Clarity Act

This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corre...

Latest Action5/25/2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S2709-2710)